Pemphigus study digs into hidden emotional struggles
NCT ID NCT02237313
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at 48 adults with pemphigus, a rare blistering skin disease, to understand what makes them feel vulnerable during their illness. Researchers used interviews and questionnaires to explore factors like misdiagnosis, differences in how patients and doctors see disease severity, and how patients use health information. The goal was to identify patterns that could help improve support for patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors identify which pemphigus patients need extra psychological support, leading to better overall care.
- What could go wrong
- This is a small, completed observational study (48 people) that only identifies factors—it does not test a treatment, so it won't directly change outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATOLOGICAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CH du Mans
Le Mans, 72037, France
-
CHRU de Lille Hôpital Claude Huriez
Lille, 59037, France
-
CHU de Clermont-Ferrand Hôpital d'Estaing
Clermont-Ferrand, 63003, France
-
Centre hospitalier de Cornouaille
Quimper, 29107, France
-
Hôpital Avicenne
Bobigny, 93000, France
-
Hôpital Haut-Lévêque
Pessac, 33604, France
-
Hôpital La Timone, Assistance publique hôpitaux de Marseille-Aix
Marseille, France
-
Hôpital Robert Debré, chu de Reims
Reims, 51 092, France
-
University Hospital of Rouen
Rouen, 76031, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Engineered immune cells take aim at blistering skin disease
- Can an extra shot boost COVID protection in autoimmune patients?
- Laser and steroid mouthwash aim to tame painful mouth sores in autoimmune disease
- Scientists probe hidden clot risks in autoimmune skin disorders
- Experimental CAR-T injection aims to tame autoimmune diseases
- New drug B007 aims to tame pemphigus with fewer meds